RNA, U6atac small nuclear 35, pseudogene (RNU6ATAC35P)

RNA, U6atac small nuclear 35, pseudogene (RNU6ATAC35P), is a human pseudogene classified as a long non-coding RNA (lncRNA) and is related to the family of small nuclear RNAs (snRNAs) involved in RNA splicing[1][2][8]. As a pseudogene, it is not believed to encode a functional protein or RNA but reflects the evolutionary byproducts of active snRNAs, specifically the U6atac snRNA[1][2][5]. U6atac snRNA itself is a component of the minor (U12-dependent) spliceosome, but pseudogene copies like RNU6ATAC35P generally lack biological activity, therapeutic significance, or validated disease associations[1][2][5][8]. There are no known drugs, biomarkers, or clinical uses for this pseudogene, and it is not considered a therapeutic target. The gene is annotated as a pseudogene, meaning it does not produce a functional snRNA and is instead a non-coding remnant of a once-functional gene[1][2][8]. Pseudogenes of small nuclear RNAs (like U6atac) can arise through retrotransposition or template switching but typically lack functional roles or disease relevance[5][3]. There is no evidence from current biology resources that RNU6ATAC35P is involved in any biological pathway, is a biomarker, or is targeted by any pharmaceutical agent[1][2][8]. Its only alias is its systematic gene symbol, and it follows the nomenclature and genomic features typical of snRNA pseudogenes[1][2][8].

Other names

RNU6ATAC35P